Results 161 to 170 of about 1,282,511 (265)
Apex Part 2 Trial in Progress: A Phase 2 Open-Label Clinical Study of Bezuclastinib in Adult Patients with Advanced Systemic Mastocytosis [PDF]
Isaac Goncalves, Stephen J. Fuller, Jason Gotlib, Pankit Vachhani, Vinod Pullarkat, Daniel J. DeAngelo, Saskia K. Klein, Wolfgang R. Sperr, Karin Hartmann, Khalid Shoumariyeh, Jens Panse, Teng Fong Ng, Miguel Piris‐Villaespesa, Tsewang Tashi, Anthony M. Hunter, Prithviraj Bose, Cecilia Y. Arana Yi, Manish Jain, Helena Pomares, Tracy I. George, Jay Patel, Cristina Papayannidis, Minakshi Taparia, Bulai Livideanu Cridtina, Juliana Schwaab, Ingunn Dybedal, Jonathan Lambert, Tania Jain, E. Wierzbicka-Hainaut, Olivier Hermine, Massimiliano Bonifacio, Gabriela Hobbs, Michael W. Deininger, Amanda Pilla, Marcus A. Carden, Deepti Radia +35 moreopenalex +1 more sourceP1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL
, 2023 Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Sigurd Broesby‐Olsen, Tracy I. George, Jens Panse, Iván Álvarez‐Twöse, Deepti Radia, Tsewang Tashi, C. Bulaï Livideanu, Vito Sabato, Paul Van Daele, Sonia Cerquozzi, Ingunn Dybedal, Andreas Reiter, Celalettin Üstün, Philippe Schafhausen, Prithviraj Bose, Daniel J. DeAngelo, Lindsay Rein, Pankit Vachhani, Massimo Triggiani, Mark Rafferty, Nauman M. Butt, Stephen T. Oh, Friederike Wortmann, Johanna Ungerstedt, Minakshi Taparia, Andrew Kuykendall, Cecilia Arana Yi, Mattias Mattsson, William Shomali, Matthew P. Giannetti, Ilda Bidollari, Huimin Lin, Robyn M. Scherber, Maria Roche, Cem Akin, Marcus Maurer +40 moreopenalex +1 more sourceBullous mastocytosis
Indian Journal of Dermatology, 2007 Mastocytosis is a condition characterized by the disorderly infiltration of mast cells in several tissues and comprises many different clinical situations varying from indolent cutaneous forms to malignant and systemic conditions. Bullous mastocytosis is Nayak Surajit, Acharjya Basanti, Devi Basanti, Behera Samira +3 moredoaj Overall Survival and Duration of Treatment in Patients with Advanced Systemic Mastocytosis Receiving Avapritinib Versus Midostaurin or Best Available Therapy in a Real-World Setting [PDF]
Andreas Reiter, Jason Gotlib, Iván Álvarez‐Twöse, Deepti Radia, Johannes Luebke, Priyanka Bobbili, Aolin Wang, Saša Dimitrijević, Erin Sullivan, Juliana Schwaab, Ilene Galinsky, Cecelia Perkins, Wolfgang R. Sperr, Priya Sriskandarajah, Manasi Mohan, Teshawna Badu, Mei Sheng Duh, Peter Valent, Daniel J. DeAngelo +18 moreopenalex +1 more sourceStandards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
Journal of Allergy and Clinical Immunology: In Practice, 2022 K. Sotlar, T. George, P. Kluin, A. Reiter, J. Schwaab, J. Panse, K. Brockow, K. Hartmann, W. Sperr, T. Kristensen, B. Nedoszytko, M. Carter, P. Bonadonna, J. Lyons, H. Kluin-Nelemans, O. Hermine, C. Akin, S. Broesby‐Olsen, G. Hoermann, M. Triggiani, J. Butterfield, M. Jawhar, J. Gotlib, D. Metcalfe, A. Órfão, M. Arock, P. Valent, H. Horny +27 moresemanticscholar +1 more sourceNovel approaches to treating advanced systemic mastocytosis
Clinical Pharmacology: Advances and Applications, 2019 JA Gilreath,1 L Tchertanov,2 MW Deininger31Department of Pharmacotherapy, College of Pharmacy and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; 2Centre de Mathématiques et de Leurs Applications (CMLA-CNRS), ENS ...Gilreath JA, Tchertanov L, Deininger MWdoaj
